Skip to content
★ Sign in to follow
KP

Kangmei Pharmaceutical Co., Ltd. Stock: price and insider trades · China

康美药业

CN·Mcap CN¥18BHealth Care

Kangmei Pharmaceutical Co., Ltd.: what insiders have been doing

Kangmei Pharmaceutical Co., Ltd. has a thin disclosure history in our data (latest filing: 14 February 2022). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€154,092
1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,107 of 26,897 companies
31.9
score / 100
Value
23
Quality
41
FCF yld-0.6%
Earn yld0.1%
EV/EBITDA48.7x
ROE0.4%
Gross mgn20%
Net mgn0.2%
Debt/EBITDA0.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥1.30
Analyst consensus
·
Income statement
RevenueCN¥5.3B
Gross profitCN¥1B20% margin
EBITDACN¥372.9M7% margin
Net incomeCN¥10.3M0.6% margin
Valuation
P/Book2.5x
Beta0.58
Balance sheet & cash
Market capCN¥18B
Total debtCN¥184.4M
Free Cash Flow-CN¥105.7M
Debt / Equity2%
Profitability & ownership
ROE0.4%
ROA-1.1%
% insiders26.6%
% institutions5.5%
Last declaration on 14 February 2022
Declarations1 total
  • ▼
    副总经理Executives
    1M CNY30SSE
    350,000 shares100.0% of flowA股XSHGSSE:173000005284945700

1 of 1 declaration

About Kangmei Pharmaceutical Co., Ltd.

康美药业 is a Chinese company specializing in the pharmaceutical and healthcare industry. It is listed on the Shanghai Stock Exchange (XSHG).

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations